Integrated Wealth Management (Palm Desert)’s AstraZeneca AZN Stock Holding History

Integrated Wealth Management (Palm Desert)’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-45	Closed	-$3K	–	293
2016 Q3	$3K	Sell	45 -500	-92%	-$32.7K	﹤0.01%	981
2016 Q2	$33K	Hold	545	–	–	0.01%	484
2016 Q1	$31K	Sell	545 -144	-21%	-$8.65K	0.01%	458
2015 Q4	$47K	Buy	689 +644	+1,431%	+$42.2K	0.02%	401
2015 Q3	$3K	Hold	45	–	–	﹤0.01%	1016
2015 Q2	$3K	Hold	45	–	–	﹤0.01%	1035
2015 Q1	$3K	Buy	+45	New	+$3.13K	﹤0.01%	1006

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 28.54% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Integrated Wealth Management (Palm Desert)'s AZN Position: Q4 2016 in Review

Integrated Wealth Management (Palm Desert) sold out of AstraZeneca (AZN) in Q4 2016, closing a stake of 45 shares — an estimated $3K sold.

Integrated Wealth Management (Palm Desert) first reported a position in AZN in Q1 2015 and held it in 7 quarters. The position peaked at $47K in Q4 2015. 450 funds tracked by Wall St. Rank hold AZN as of Q4 2016.

Integrated Wealth Management (Palm Desert) reported no remaining AstraZeneca position as of Q4 2016 after selling out during the quarter.
Integrated Wealth Management (Palm Desert) sold 45 AstraZeneca shares in Q4 2016, an estimated $3K.
Integrated Wealth Management (Palm Desert) first reported a position in AstraZeneca in Q1 2015 and held it in 7 quarters.
Integrated Wealth Management (Palm Desert)'s AstraZeneca position peaked at $47K in Q4 2015.
450 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2016.

Based on Integrated Wealth Management (Palm Desert)'s 13F filing for Q4 2016, filed 6 Jan 2017.